Streetbeat News

Products Services

AMGN

Amgen has presented new data for its drug Krystexxa (Pegloticase) at the American Society Of Nephrology Kidney Week. The data shows a decrease in blood pressure during treatment in chronic gout refractory patients to oral urate-lowering treatment, both with and without chronic kidney disease.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 12:07 pm

TOVX

Theriva Biologics and Sant Joan de Déu-Barcelona Children's Hospital are advancing their strategic collaboration to explore the combination of VCN-01 with topoisomerase inhibitors for cancer treatment.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 12:06 pm

UPWK

Upwork has launched the Upwork Research Institute, aimed at guiding organizations through workforce transformation and redefining the future of work.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 12:03 pm

AAPL

BBY

Apple Inc.'s new M3 MacBook Pro is already discounted by $100 on Best Buy Co Inc., merely two days after its launch. The discount is applicable on all configurations and is offered to My Best Buy Plus or Total members, both existing and new.

Portfolio Pulse from Rounak Jain

November 02, 2023 | 12:02 pm

AUVI

Applied UV has secured a new patent approval from the USPTO for an interchangeable drain disinfecting device. The device is currently undergoing validation at Mt Sinai Hospital.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 12:02 pm

RGEN

Repligen Corporation has announced the commercial launch of TangenX SC, the industry's first holder-free, self-contained tangential flow filtration device. This innovative product is expected to revolutionize the bioprocessing industry.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:56 am

KURA

MRTX

Kura Oncology and Mirati Therapeutics have entered into a clinical collaboration and supply agreement to evaluate KO-2806 and Adagrasib for non-small cell lung cancer.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:55 am

LNG

Cheniere Energy has announced that its subsidiary, Cheniere Marketing, has signed a long-term liquefied natural gas (LNG) sale and purchase agreement with Foran Energy Group Co. Ltd.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:50 am

BDX

Becton, Dickinson and Company (BDX) has launched a new needle-free blood draw technology that is compatible with integrated catheters. This innovation aligns with the company's vision of a 'one-stick hospital stay'.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:50 am

INTS

Intensity Therapeutics presented safety, tolerability, and efficacy data from its ongoing Phase 1/2 trial of INT230-6 in relapsed, refractory, and metastatic sarcomas at the Connective Tissue Oncology Society 2023 Annual Meeting.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 11:48 am